Heart failure is a devastating clinical syndrome, but current therapies are unable to abolish
the disease burden. New strategies to treat or prevent heart failure are urgently needed …

Heart failure (HF) is a common, disabling, and costly disease. Despite major advances in
medical therapy, morbidity and mortality remain high, in part because current …

The mitochondrial electron transport chain (mtETC) requires mainly coenzyme Q10
(CoQ10), copper (Cu 2+), calcium (Ca 2+), and iron (Fe 2+) ions for efficient ATP production …

Aims We aimed to assess determinants of anorexia, that is loss of appetite in patients with
heart failure (HF) and aimed to further elucidate the association between anorexia …

Hospitalization for heart failure (HF) marks a substantial crossroad for patients, as greater
than one-third will be re-hospitalized or dead within 90 days post-discharge. For patients …

OBJECTIVES: To examine the effects of pomegranate extract on inflammation and oxidative
stress and the development of spontaneous occlusive coronary artery atherosclerosis in the …

Heart failure is a common condition in the Western world, particularly among elderly persons
and with an ever-aging population, the incidence is expected to increase. Diet in the setting …

There is evidence demonstrating that heart failure (HF) occurs in 1–2% of the global
population and is often accompanied by comorbidities which contribute to increasing the …

Chronic obstructive pulmonary disease (COPD), a common and heterogeneous respiratory
disease, is characterized by persistent and incompletely reversible airflow limitation …

Although well documented drug therapies are available for the management of ventricular
hypertrophy (VH) and heart failure (HF), most patients nonetheless experience a downhill …